Results 171 to 180 of about 777,510 (311)

Catastrophic health expenditure and commercial health insurance purchase: evidence from China. [PDF]

BMC Health Serv Res
Song S, Li C, Li Y.
europepmc   +1 more source

IMPACT ASSESSMENT ON MILK INCENTIVE POLICIES IN TURKEY: ANTALYA PROVINCE CASE [PDF]

Agricultural policy instruments are implementing in different ways among all agricultural based activities. These instruments have been performed for livestock including dairy cattle and milk for many years in Turkey.
Karaman, Suleyman, Mencet, M. Nisa, Sayin, Cengiz   +2 more
core   +1 more source

Identification of Histone Deacetylase Inhibitor Targeting Type I Interferon and B Cell Abnormalities in Systemic Lupus Erythematosus

Arthritis &Rheumatology, EarlyView.
Objective Systemic lupus erythematosus (SLE) is characterized by increased Type I interferon (IFN‐I) and autoantibody production. This study aimed to identify drugs that can inhibit both IFN‐I and autoantibody production. Methods We identified an inhibitor of IFN‐I production from a chemical library.
Takehiro Hirayama, Hachiro Konaka, Yasuhiro Kato, Takayuki Shibahara, Chisato Nishizawa, Kohei Tsujimoto, JeongHoon Park, Eri Itotagawa, Tatsunori Jo, Masayuki Nishide, Sumiyuki Nishida, Yoshihito Shima, Masashi Narazaki, Wataru Aoki, Ken J Ishii, Hyota Takamatsu, Atsushi Kumanogoh   +16 more
wiley   +1 more source

Performance of large language models on sleep medicine certification examination: a comprehensive multi-model analysis. [PDF]

Front Med (Lausanne)
Koç A, Ataş AE, Yosunkaya Ş, Vatansev H.   +3 more
europepmc   +1 more source

Why do variance swaps exist? [PDF]

This paper studies the determinants of the variance risk premium and concludes on the hedging possibilities offered by variance swaps. We start by showing that the variance risk premium responds to changes in higher order moments of the distribution of ...
Alfonso Novales Cinca, Belén Nieto, Gonzalo Rubio   +2 more
core  

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Modeling Financial Insolvency and Income Loss Insurance in Head and Neck Cancer. [PDF]

J Health Econ Outcomes Res
Araujo AV, Bartho MJ, Low GMI, Li RJ.
europepmc   +1 more source

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

From value orientations to payment: health vs. environmental consciousness and willingness to pay for green hotels via green literacy. [PDF]

Front Psychol
Chen Z, Lin C.
europepmc   +1 more source

‘Literal torture’: Vulnerability, resilience and young people's experiences of pressure in physical education

British Educational Research Journal, EarlyView.
Abstract This paper combines vulnerability and resilience theory to explore the pressure young people experience in Physical Education (PE) and sport at secondary school. The theoretical framework was used to understand both how young people experience PE in school and how vulnerability and resilience function interdependently in social contexts like ...
David Littlefair, Michael Jopling
wiley   +1 more source